KYLYS AESTHETICS was mentioned alongside TEOXANE Laboratories and AMiiA Clinique in a report broadcast by RTS – Radio Télévision Suisse, focusing on hyaluronic acid and its growing applications in aesthetic and regenerative medicine.
For KYLYS AESTHETICS, this recognition reflects several years of dedicated work at the intersection of science and medical innovation. Since the early stages of our technology’s development, our efforts have been guided by three key pillars:
- scientific research
- technological innovation
- clinical rigor
Our ambition is clear: to go beyond the traditional volumizing effect of conventional dermal fillers and develop a next-generation hyaluronic acid platform with regenerative properties, grounded in scientific research and supported by robust preclinical and clinical data.
Hyaluronic acid has long been a cornerstone of aesthetic medicine. However, new advances in biomaterials and formulation science are opening the door to more sophisticated solutions that not only restore volume but also interact more naturally with surrounding tissues.
At KYLYS, our work focuses on developing technologies that improve tissue integration while enabling new regenerative approaches in aesthetic medicine. Our goal is to contribute to the evolution of the field toward safer, longer-lasting, and biologically active treatments.
🎥 The full report is available here:
Swiss innovation in aesthetic medicine continues to evolve, and we are proud to contribute to this dynamic ecosystem alongside partners such as FONGIT, Innosuisse, Genolier Innovation Hub, ENTOURAGE Medical Esthetic Solutions SA, and Dr. Marco Cerrano.